Plexin A2 regulated the metastasis in breast cancer through MCM7

Breast cancer is a malignant tumour that affects women's health. In clinical practice, breast cancer is mainly treated by surgery, radiation, and drugs, but the risk of metastasis and recurrence is high, and metastasis is inextricably linked to the transcription and regulation of many molecule. In this manuscript, we first found 27 highly expressed genes and 58 lower expressed genes related to metastasis, then Plexin A2 was found highly expressed in the tissues from metastasis breast cancer and exerted as promote role in cell proliferation, migration, and invasion of MDA-MB-231. Also, CoIP-MS was used to detect the proteins which bind with Plexin A2 and differential expressed in highly metastasis MDA-MB-231 and 9 proteins were selected in highly invasion MDA-MB-231. Plexin A2 was found bind with MCM7 in a binding set of S45 through a phosphoserine/threonine binding group in highly metastasis MDA-MB-231. Moreover, Plexin A2 and MCM7 was found involved in cell proliferation, apoptosis inhibition, migration, and invasion of MDA-MB-231. In conclusion, Plexin A2 bind with MCM7 in a binding set of S45 through a phosphoserine/threonine binding group, Plexin A2 and MCM7 was involved in cell proliferation, apoptosis inhibition, migration, and invasion of MDA-MB-231. These results showed that Plexin A2 can be considered as a promising biomarker in breast cancer metastasis.